Dopamine-receptor agonists: Mechanisms underlying autoreceptor selectivity

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of neural transmission

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/BF01260414PMID 3894582
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacological specificity of conditioned avoidance response inhibition in rats: inhibition by neuroleptics and correlation to dopamine receptor blockade.

  2009cited by this paper
• Effects of B-HT 920 and B-HT 933 on dopamine and noradrenaline autoreceptors in the rat brain.

  2009cited by this paper
• Postsynaptic dopamine agonistic effects of 3-PPP enantiomers revealed by bilateral 6-hydroxy-dopamine lesions and by chronic reserpine treatment in rats

  2005cited by this paper
• Dopamine receptor agonists: Intrinsic activity vs. state of receptor

  2005cited by this paper
• In vivo displacement by 3-PPP enantiomers of N,N-dipropyl-5,6-ADTN from dopamine receptor-binding sites in rat striatum

  2005cited by this paper
• Dopamine receptor agonists: Mechanisms underlying autoreceptor selectivity II. Theoretical considerations

  2005cited by this paper
• Dopamine D2 receptors in brain and anterior pituitary recognize agonist and antagonist actions of (−)-3-PPP

  2005cited by this paper
• In vitro effect of the racemic mixture and the (−)enantiomer of N-n-propyl-3-(3-hydroxyphenyl)-piperidine (3-PPP) on postsynaptic dopamine receptors and on a presynaptic dopamine autoreceptor

  2005cited by this paper
• Behavioral and biochemical effects of subchronic treatment with (−)3-(3-hydroxyphenyl)-N-n-propylpiperidine in the rat: Dopamine receptor sensitivity and tolerance

  2005cited by this paper
• Demonstration of autoreceptors on dopamine neurons in different brain regions of rats treated with gammabutyrolactone

  2005cited by this paper
• Effect of a stereospecific D2-dopamine agonist on acetylcholine concentration in corpus striatum of rat brain

  2005cited by this paper
• Sub-chronic administration of (−)-3-PPP and central dopamine receptor sensitivity changes

  2005cited by this paper
• Differential effects of the enantiomers of 3-PPP on dopamine D1-receptors of isolated rabbit retina

  2005cited by this paper
• A behavioural study of the changes in the central nervous system of mice after subchronic treatment with the selective dopamine autoreceptor agonist 3-PPP (dl-3-[3-hydroxyphenyl]-N-n-propylpiperidine)

  2005cited by this paper
• Antidyskinetic action of 3-PPP, a selective dopaminergic autoreceptor agonist, in Cebus monkeys with persistent neuroleptic-induced dyskinesias

  2005cited by this paper
• Responses to apomorphine, amphetamine, and neuroleptics in schizophrenic subjects

  2004cited by this paper
• The effect of the enantiomers of 3-PPP on conditioned avoidance responding in the rat

  2004cited by this paper
• Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP

  2004cited by this paper
• Dopamine receptor agonistic and antagonistic effects of 3-PPP enantiomers

  2004cited by this paper
• Relation between central sympathoinhibitory and peripheral pre-and postsynaptic α-adrenoceptors as evaluated by different clonidine-like substances in rats

  2004cited by this paper
• Ontogenic variations in responses to l-DOPA and monoamine receptor-stimulating agents

  2004cited by this paper
• Effects of (-)3-PPP on acquisition and retention of a conditioned avoidance response in the rat

  2004cited by this paper
• Direct evidence for involvement of dopaminergic inhibition and cholinergic activation in yawning

  2004cited by this paper
• 3-PPP Enantiomers and Brain Sigma Opiate Sites: Discrepancies between in vitro and in vivo Observations

  1986cited by this paper
• Central dopaminergic properties of HW-165 and its enantiomers; Trans-octahydrobenzo(f)quinoline congeners of 3-PPP

  1986cited by this paper
• Evidence for autoreceptor modulation of endogenous dopamine release from rabbit caudate nucleus in vitro.

  1985cited by this paper
• Agonist and antagonist effects of 3-PPP enantiomers on functional dopamine autoreceptors and postsynaptic dopamine receptors in vitro.

  1985cited by this paper
• Is inhibitio of striatal synaptosomal tyrosine hydroxylation by dopamine agonists a measure of dopamine autoreceptor function?

  1985cited by this paper
• Lack of functional evidence for the involvement of sigma opiate receptors in the actions of the 3-PPP enantiomers on central dopaminergic systems: discrepancies between in vitro and in vivo observations.

  1985cited by this paper
• Dopamine receptor-mediated hypothermia induced in rats by (+)-, but not by (-)-3-PPP.

  1985cited by this paper
• Effect of dopaminergic drugs on striatal acetylcholine concentration

  1985cited by this paper
• An electrophysiological analysis of the actions of the 3-PPP enantiomers on the nigrostriatal dopamine system

  1985cited by this paper
• TREATMENT OF PARKINSONʼS DISEASE WITH A DOPAMINE PARTIAL AGONIST

  1984cited by this paper
• Interaction of (+)- and (-)-3-PPP with the dopamine receptor in the anterior pituitary gland.

  1984cited by this paper
• Clinical Effects of Apomorphine in Schizophrenia

  1984cited by this paper
• Differential effects of the stereoisomers of 3PPP in dopaminergic and cholinergic neurotransmission in superfused slices of the corpus striatum

  1984cited by this paper
• Agonist high- and low-affinity states of the D2-dopamine receptor in calf brain. Partial conversion by guanine nucleotide.

  1984cited by this paper
• Interaction of (+)- and (−)-3-PPP with the dopamine receptor in the anterior pituitary gland

  1984cited by this paper
• Transdihydrolisuride, a partial dopamine receptor antagonist: effects on monoamine metabolism.

  1984cited by this paper
• Dopamine Synthesis in Synaptosomes: Relation of Autoreceptor Functioning to pH, Membrane Depolarization, and Intrasynaptosomal Dopamine Content

  1984cited by this paper
• (+)- and (-)-3-PPP exhibit different intrinsic activity at striatal dopamine autoreceptors controlling dopamine synthesis.

  1984cited by this paper
• The yawning-penile erection syndrome as a model for putative dopamine autoreceptor activity.

  1984cited by this paper
• Stimulation of presynaptic dopamine autoreceptors by 4-(2-di-n-propylaminoethyl) indole (DPAI).

  1984cited by this paper
• Dopaminergic 3H-agonist receptors in rat brain. New evidence on localization and pharmacology.

  1984cited by this paper
• Assessment of dopamine autoreceptor agonist properties of apomorphine, (+)-3-PPP and (-)-3-PPP by recording of yawning behaviour in rats.

  1984cited by this paper
• THE EFFECTS OF NOVEL DOPAMINERGIC AGONISTS ON THE NIGROSTRIATAL DOPAMINE SYSTEM

  1984cited by this paper
• A10 dopamine neurons: role of autoreceptors in determining firing rate and sensitivity to dopamine agonists.

  1984cited by this paper
• The effectiveness of yohimbine in blocking rat central dopamine autoreceptors in vivo

  1984cited by this paper
• Two dopamine receptors: biochemistry, physiology and pharmacology.

  1984cited by this paper
• Action of putative dopamine receptor agonists, TL-99, 3-PPP and RDS-127 on substantia nigra neurons.

  1984cited by this paper
• The Dopamine/Neuroleptic Receptor

  1984cited by this paper
• Effects of apomorphine, TL-99 and 3-PPP on yawning in rats.

  1984cited by this paper
• The effects of SCH 23390, YM 09151-2, (+)- and (-)-3-PPP and some classical neuroleptics on D-1 and D-2 receptors in rat neostriatum in vitro.

  1984cited by this paper
• Presynaptic dopaminergic agonists modify brain glucose metabolism in a way similar to the neuroleptics.

  1984cited by this paper
• Psychotomimetic opiate receptors labeled and visualized with (+)-[3H]3-(3-hydroxyphenyl)-N-(1-propyl)piperidine.

  1984cited by this paper
• Antagonism by haloperidol of the suppression of exploratory locomotor activity induced by the local application of(−)3-(3-hydroxyphenyl)-N-n-propylpiperidine into the nucleus accumbens of the rat

  1984cited by this paper
• Effects of dopamine agonists, catecholamine depletors, and cholinergic and GABAergic drugs on acute dyskinesias in squirrel monkeys

  1983cited by this paper
• Stimulation of postsynaptic DA2 receptors produces jerks in reserpine‐treated rats

  1983cited by this paper
• Similarities of the effects of apomorphine and 3-PPP on serotonin neurons.

  1983cited by this paper
• Suppression of exploratory locomotor activity in the rat by the local application of 3-PPP enantiomers into the nucleus accumbens.

  1983cited by this paper
• Avoidance and ICSS behavioral models dissociate TL-99 and 3-PPP from dopamine receptor antagonists.

  1983cited by this paper
• Differential behavioural effects of dopamine agonists in developing rats: a study of 3-PPP enantiomers.

  1983cited by this paper
• Differential effects of the enantiomers of 3-(3-hydroxyphenyl)-N-n-propylpiperidine (3-PPP) at dopamine receptor sites.

  1983influential reference
• Characterization of dopamine autoreceptor and [3H]spiperone binding sites in vitro with classical and novel dopamine receptor agonists.

  1983cited by this paper
• Low-dose apomorphine and bromocriptine in neuroleptic-induced movement disorders.

  1983cited by this paper
• Dual action on central dopamine function of transdihydrolisuride, a 9, 10-dihydrogenated analogue of the ergot dopamine agonist lisuride.

  1983cited by this paper
• Further functional in vitro comparison of pre- and postsynaptic dopamine receptors in the rabbit caudate nucleus

  1983cited by this paper
• SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems.

  1983cited by this paper
• Failure of 3-PPP to activate dopamine autoreceptors in vitro.

  1983cited by this paper
• Neuropharmacological studies in rodents on the action of RX 781094, a new selective alpha 2-adrenoceptor antagonist.

  1983cited by this paper
• Biphasic effects of some dopamine agonists on striatal acetylcholine concentrations.

  1983cited by this paper
• In vivo dopamine receptor binding studies with a non-radioactively labeled agonist, dipropyl-5,6-ADTN.

  1983cited by this paper
• Diastolic properties of the hypertrophied left ventricle in spontaneously hypertensive rats.

  1983cited by this paper
• Electrophysiological studies on EMD 23 448, an indolyl-3-butylamine, in the rat: a putative selective dopamine autoreceptor agonist.

  1983cited by this paper
• Dopamine receptors involved in prolactin secretion pharmacologically characterized by means of 3-PPP enantiomers.

  1983cited by this paper
• Chloral hydrate anesthesia alters the responsiveness of dorsal raphe neurons to psychoactive drugs.

  1983cited by this paper
• SCH 23390 - the first selective dopamine D-1 antagonist.

  1983cited by this paper
• Inhibition of dopamine synthesis in striatal synaptosomes by lisuride: Stereospecific reversal by (−)-sulpiride

  1983cited by this paper
• The striatal cholinergic interneuron: synaptic target of dopaminergic terminals?

  1983cited by this paper
• Postsynaptic striatal dopamine agonist or antagonist actions of (+) or (-) 3-PPP and modification after receptor deafferentation.

  1983cited by this paper
• On the mode of action of 3-(3-hydroxyphenyl)-N-n-propylpiperidine, 3-PPP, and its enantiomers. With particular reference to dopaminergic mechanisms in the central nervous system.

  1983cited by this paper
• Centrally acting dopamine receptor stimulants with special reference to dopamine autoreceptors and stereoselectivity

  1983cited by this paper
• Effect of dopamine agonists and neuroleptic agents on striatal acetylcholine transmission in the rat: evidence against dopamine receptor multiplicity.

  1982cited by this paper
• Dopamine agonists stimulate protein carboxylmethylation in striatal synaptosomes.

  1982cited by this paper
• Anterior pituitary dopamine receptors. Demonstration of interconvertible high and low affinity states of the D-2 dopamine receptor.

  1982cited by this paper
• Is 3-PPP a potential antipsychotic agent? Evidence from animal behavioral studies.

  1982cited by this paper
• Is TL-99 a selective presynaptic dopamine receptor agonist?

  1982cited by this paper
• Dopaminergic activity of substituted 6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines.

  1982cited by this paper
• Effects of putative dopamine autoreceptor agonists in pharmacological models related to dopaminergic and neuroleptic activity.

  1982cited by this paper
• Specific alterations in local cerebral glucose utilization following striatal lesions.

  1982cited by this paper
• On the mechanism of presynaptic autoreceptor-mediated inhibition of transmitter synthesis in dopaminergic nerve terminals.

  1982cited by this paper
• 3-Phenylpiperidines. Central dopamine-autoreceptor stimulating activity.

  1981cited by this paper
• Behavioural and neurochemical studies on apomorphine-induced hypomotility in mice.

  1981cited by this paper
• Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum

  1981cited by this paper
• Differential effects of dopamine agonists in mature and immature rats.

  1981cited by this paper
• Injection of low doses of apomorphine into the nucleus accumbens of rats reduces locomotor activity.

  1981cited by this paper
• Pharmacological profiles of the putative dopamine autoreceptor agonists 3-PPP and TL-99.

  1981cited by this paper
• Differential functional ontogeny of dopamine presynaptic receptor regulation.

  1981cited by this paper
• Effect of 3-PPP, a putative dopamine autoreceptor agonist, on rat serum prolactin levels.

  1981cited by this paper
• Evidence that LY-141865 specifically stimulates the D-2 dopamine receptor

  1981cited by this paper

• The influence of dopamine autoreceptors on temperament and addiction risk.

  2023cites this paper
• Dopamine D 2 Partial Agonists – Discovery, Evolution, and Therapeutic Potential

  2019cites this paper
• Stereoselective synthesis of (-)-3-PPP through palladium-catalysed unactivated C(sp3)-H arylation at the C-3 position of l-pipecolinic acid

  2017cites this paper
• Agonist and Antagonist Effects of Aripiprazole on D2-Like Receptors Controlling Rat Brain Dopamine Synthesis Depend on the Dopaminergic Tone

  2015cites this paper
• The Application of Novel Positron Emission Tomography (PET) Radioligands as Imaging Biomarkers of Neurochemical Changes in the Brain: Relevance in Schizophrenia and Alzheimer's disease

  2014cites this paper
• Diverse strategies targeting alpha 7 homomeric and alpha 6 beta 2 * heteromeric nicotinic acetylcholine receptors for smoking cessation

  2014cites this paper
• Differential Effects of Cocaine on Dopamine Neuron Firing in Awake and Anesthetized Rats

  2012cites this paper
• Dopamine Receptors and the Treatment of Schizophrenia

  2010cites this paper
• Effects of repeated and acute aripiprazole or haloperidol treatment on dopamine synthesis in the dorsal striatum of young rats: comparison to adult rats

  2010cites this paper
• Synthesis and evaluation of a set of 4-phenylpiperidines and 4-phenylpiperazines as D2 receptor ligands and the discovery of the dopaminergic stabilizer 4-[3-(methylsulfonyl)phenyl]-1-propylpiperidine (huntexil, pridopidine, ACR16).

  2010cites this paper
• An overview on benzylisoquinoline derivatives with dopaminergic and serotonergic activities.

  2009cites this paper
• THE EFFECT OF ARIPIPRAZOLE ON PREPULSE INHIBITION OF THE STARTLE RESPONSE IN NORMAL AND HYPERDOPAMINERGIC STATES IN RATS

  2008cites this paper
• Adaptive properties and heterogeneity of dopamine D(2) receptors - pharmacological implications.

  2008cites this paper
• In vitro functional characteristics of dopamine D2 receptor partial agonists in second and third messenger-based assays of cloned human dopamine D2Long receptor signalling

  2007cites this paper
• Dopamine D2 receptor partial agonists display differential or contrasting characteristics in membrane and cell-based assays of dopamine D2 receptor signaling.

  2007cites this paper
• Bifeprunox: a novel antipsychotic agent with partial agonist properties at dopamine D2 and serotonin 5-HT1A receptors

  2007cites this paper
• The enigma of mixed dementia

  2007cites this paper
• Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.

  2006cites this paper
• Kappa-Opioid Agonist U69593 Potentiates Locomotor Sensitization to the D2/D3 Agonist Quinpirole: Pre- and Postsynaptic Mechanisms

  2006cites this paper
• The partial dopamine D2-like receptor agonist terguride functions as an agonist in preweanling rats after a 5-day reserpine regimen

  2006influential citation
• Effects of a partial D2-like receptor agonist on striatal dopamine autoreceptor functioning in preweanling rats.

  2006cites this paper
• Pre- and postsynaptic actions of a partial D2 receptor agonist in reserpinized young rats: longevity of agonistic effects.

  2006cites this paper
• Effects of low, autoreceptor selective doses of dopamine agonists on the discriminative cue and locomotor hyperactivity produced by d-amphetamine

  2005cites this paper
• Partial agonism and schizophrenia Partial agonism and schizophrenia

  2005cites this paper
• Sub-chronic administration of (−)-3-PPP and central dopamine receptor sensitivity changes

  2005cites this paper
• Dopamine receptor agonists: Mechanisms underlying autoreceptor selectivity II. Theoretical considerations

  2005cites this paper
• Dopamine D-2 agonists with high and low efficacies: differentiation by behavioural techniques

  2005cites this paper
• The partial D2-like dopamine receptor agonist terguride acts as a functional antagonist in states of high and low dopaminergic tone: evidence from preweanling rats

  2005cites this paper
• Dopamine receptors, controlling dopamine levels in rat adrenal glands — comparison with central dopaminergic autoreceptors

  2005cites this paper
• (+)-UH 232 and (+)-UH 242: Novel stereoselective dopamine receptor antagonists with preferential action on autoreceptors

  2005cites this paper
• The 5-HT1A receptor antagonist (S)-UH-301 decreases dopamine release in the rat nucleus accumbens and striatum

  2005cites this paper
• Suppression of neuroleptic-induced persistent abnormal movements in Cebus apella monkeys by enantiomers of 3-PPP

  2005cites this paper
• D-2 but not D-1 dopamine agonists produce augmented behavioral response in rats after subchronic treatment with methamphetamine or cocaine

  2005cites this paper
• Lack of G protein-coupled sigma receptors in rat brain membranes: receptor-mediated high-affinity GTPase activity and [35S]GTPγS binding studies

  2005cites this paper
• Partial agonism and schizophrenia

  2005cites this paper
• Pharmacologic properties of (−)-3PPP (preclamol) in man

  2005cites this paper
• In vivo displacement by 3-PPP enantiomers of N,N-dipropyl-5,6-ADTN from dopamine receptor-binding sites in rat striatum

  2005cites this paper
• Partial Dopamine Agonists and the Treatment of Psychosis

  2005cites this paper
• The reduction of water intake in rats caused by a low dose of apomorphine is unaltered by α-methyl-p-tyrosine: are autoreceptors not involved?

  2005cites this paper
• In vivo dopamine (DA) receptor binding and behavioural effects of the putative DA autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 in rats with a unilateral nigral 6-OH-DA lesion

  2004cites this paper
• Involvement of septal and striatal dopamine D-2 receptors in yawning behavior in rats

  2004cites this paper
• Discriminative stimulus effects of a low dose of apomorphine in the rat

  2004cites this paper
• Anxiolytic-like action of the 3-PPP enantiomers in the Vogel conflict paradigm

  2004cites this paper
• Schizophrenia: from dopamine to glutamate and back.

  2004cites this paper
• In vivo effects of aripiprazole on cortical and striatal dopaminergic and serotonergic function.

  2004cites this paper
• Brain capillaries and cholinergic neurons persist in organotypic brain slices in the absence of blood flow

  2003cites this paper
• Marklagerveränderungen bei neurodegenerativen und vaskulären Demenzerkrankungen

  2003cites this paper
• Historical aspects and future directions

  2003cites this paper
• Partial dopamine agonists in the treatment of psychosis

  2002cites this paper
• The actions of a D-1 agonist in MPTP treated primates show dependence on both D-1 and D-2 receptor function and tolerance on repeated administration

  2002cites this paper
• Studies of the Interaction between Behavioral Stereotypes and the Effects of Activation of Presynaptic Dopamine Receptors during Extinction and Amnesia in Mice

  2002cites this paper
• Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclase.

  2002cites this paper
• Reinforcing effects of D2 dopamine receptor agonists and partial agonists in rhesus monkeys.

  2001cites this paper
• In vivo characterization of novel full and partial 2-(4-aminophenyl)-N,N-dipropylethylamine dopamine D(2) receptor agonists.

  2000cites this paper
• Mapping quantitative trait loci that regulate sensitivity and tolerance to quinpirole, a dopamine mimetic selective for D(2)/D(3) receptors.

  2000cites this paper
• Relationship between modulation of the cerebellorubrospinal system in the in vitro turtle brain and changes in motor behavior in rats: effects of novel sigma ligands.

  1999cites this paper
• Dopamine D3 receptor mutant and wild‐type mice exhibit identical responses to putative D3 receptor‐selective agonists and antagonists

  1999cites this paper
• Interactions of the Novel Antipsychotic Aripiprazole (OPC-14597) with Dopamine and Serotonin Receptor Subtypes

  1999cites this paper
• Effects of the substituted (S)‐3‐phenylpiperidine (−)‐OSU6162 on PET measurements in subhuman primates: Evidence for tone‐dependent normalization of striatal dopaminergic activity

  1998cites this paper
• Phenylpiperazine derivatives with strong affinity for 5HT1A, D2A and D3 receptors.

  1998cites this paper
• Contribution of presynaptic dopaminergic receptors to the mechanism of the reactivating effects of blockade of the GABA-benzodiazepine-ionophore complex

  1998cites this paper
• Antipsychotic properties of the partial dopamine agonist (-)-3-(3-hydroxyphenyl)-N-n-propylpiperidine(preclamol) in schizophrenia.

  1998cites this paper
• A simple, non-invasive method for the measurement of reserpine-induced tremor in rats.

  1997cites this paper
• Enhancement of latent inhibition in the rat by the atypical antipsychotic agent remoxipride.

  1997cites this paper
• [The contribution of presynaptic dopaminergic receptors to the mechanism of the reactivating influences of blockade of the GABA-benzodiazepine-ionophor complex].

  1997cites this paper
• Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors.

  1997cites this paper
• Adverse effects of antipsychotic agents. Do newer agents offer advantages?

  1996cites this paper
• Partial agonistic effects of OPC-14597, a potential antipsychotic agent, on yawning behavior in rats.

  1996cites this paper
• Morphine- and cocaine-induced conditioned place preference: effects of quinpirole and preclamol.

  1996cites this paper
• Adverse Effects of Antipsychotic Agents

  1996cites this paper
• Preclamol. A "designer drug" in the treatment of advanced Parkinson's disease.

  1996cites this paper
• On the quantitative structure-activity relationships of meta-substituted (S)-phenylpiperidines, a class of preferential dopamine D2 autoreceptor ligands: modeling of dopamine synthesis and release in vivo by means of partial least squares regression.

  1995cites this paper
• Synthesis and evaluation of pharmacological and pharmacokinetic properties of monopropyl analogs of 5-, 7-, and 8-[[(trifluoromethyl)sulfonyl]oxy]-2-aminotetralins: central dopamine and serotonin receptor activity.

  1995cites this paper
• Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907.

  1995cites this paper
• New drugs for the treatment of schizophrenic patients

  1995cites this paper
• Antagonism of reserpine-induced suppression of spontaneous motor activity by stimulation of 5-HT1A receptors in rats.

  1995cites this paper
• Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways.

  1995cites this paper
• Is in vivo striatal acetylcholine output under a tonic inhibitory control by dopamine?

  1995cites this paper
• Effects of sigma receptor ligands on the extracellular concentration of dopamine in the striatum and prefrontal cortex of the rat.

  1995cites this paper
• Dopamine agonists in schizophrenia: a review.

  1995cites this paper
• Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: 1. Activation of postsynaptic D3 receptors mediates hypothermia, whereas blockade of D2 receptors elicits prolactin secretion and catalepsy.

  1995cites this paper
• Does dopamine exert a tonic inhibitory control on the release of striatal acetylcholine in vivo?

  1994cites this paper
• Preclinical findings with new antipsychotic agents: what makes them atypical?

  1994cites this paper
• CGP 25454A, a novel and selective presynaptic dopamine autoreceptor antagonist

  1994cites this paper
• Dopamine receptors: molecular biology, biochemistry and behavioural aspects.

  1994cites this paper
• Differential effects of 3-PPP enantiomers on extracellular dopamine concentration in the caudate-putamen and nucleus accumbens of rats

  1994cites this paper
• Motor effects of the partial dopamine agonist (−)‐3‐(3‐hydroxyphenyl)‐N‐n‐propylpiperidine (preclamol) in Parkinson's disease

  1994cites this paper
• Substituted (S)-phenylpiperidines and rigid congeners as preferential dopamine autoreceptor antagonists: synthesis and structure-activity relationships.

  1994cites this paper
• An autoradiographic study of the differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on striatal and extrastriatal D-1 and D-2 dopamine receptors in the rat.

  1994cites this paper
• Electrophysiological effects of putative autoreceptor-selective dopamine agonists on A10 dopamine neurons.

  1993cites this paper
• Low dose raclopride spares the extrapyramidal system in rat brain from metabolic effects.

  1993cites this paper
• Treatment of parkinson's disease with the partial dopamine agonist EMD 49980

  1993cites this paper
• Pharmacogenetics of cocaine: II. Mesocorticolimbic and striatal dopamine and cocaine receptors in C57BL and DBA mice.

  1993cites this paper
• The role of D1 and D2 receptors in the heightened locomotion induced by direct and indirect dopamine agonists in rats with hippocampal damage: an animal analogue of schizophrenia.

  1993cites this paper
• Partial dopamine receptor agonists reverse behavioral, biochemical and neuroendocrine effects of neuroleptics in the rat: potential treatment of extrapyramidal side effects.

  1993cites this paper
• Stimulation of brain dopamine autoreceptors by remoxipride administration in reserpine‐treated male rats

  1993cites this paper
• Repeated reserpine treatment alters firing pattern and responses of substantia nigral dopamine neurons.

  1993cites this paper
• New sigma-like receptor recognized by novel phenylaminotetralins: ligand binding and functional studies.

  1993cites this paper
• Understanding the Mechanism of Action of Atypical Antipsychotic Drugs

  1993cites this paper
• Effects of several partial dopamine D2 receptor agonists in Cebus apella monkeys previously treated with haloperidol.

  1993cites this paper